Learn More
Linear mixed models with normally distributed response are routinely used in longitudinal data. However, the accuracy of the assumed normal distribution is crucial for valid inference of the parameters. We present a new class of asym-metric linear mixed models that provides for an efficient estimation of the parameters in the analysis of longitudinal data.(More)
Motivated by a real data example on renal graft failure, we propose a new semiparametric multivariate joint model that relates multiple longitudinal outcomes to a time-to-event. To allow for greater flexibility, key components of the model are modelled nonparametrically. In particular, for the subject-specific longitudinal evolutions we use a spline-based(More)
We develop a spatial Poisson hurdle model to explore geographic variation in emergency department (ED) visits while accounting for zero inflation. The model consists of two components: a Bernoulli component that models the probability of any ED use (i.e., at least one ED visit per year), and a truncated Poisson component that models the number of ED visits(More)
We propose a changepoint model for the analysis of longitudinal CD4 T-cell counts for HIV infected subjects following highly active antiretroviral treatment. The profile of CD4 counts for each subject follows a simple, 'broken stick' changepoint model, with random subject-specific parameters, including the changepoint. The model accounts for baseline(More)
In many biomedical applications, researchers encounter semicontinuous data where data are either continuous or zero. When the data are collected over time the observations may be correlated. Analysis of this kind of longitudinal semicontinuous data is challenging due to the presence of strong skewness in the data. A flexible class of zero-inflated models in(More)
Christoffersen, Jacobs, and Ornthanalai (2012) (CJO) propose an interesting and useful class of generalized autoregressive conditional heteroskedasticity (GARCH)-like models with dynamic jump intensity, and find evidence that the models not only fit returns data better than some commonly used benchmarks but also provide substantial improvements in option(More)
Bioequivalence trials are usually conducted to compare two or more formulations of a drug. Simultaneous assessment of bioequivalence on multiple endpoints is called multivariate bioequivalence. Despite the fact that some tests for multivariate bioequivalence are suggested, current practice usually involves univariate bioequivalence assessments ignoring the(More)
Correlated data arise in a longitudinal studies from epidemiological and clinical research. Random effects models are commonly used to model correlated data. Mostly in the longitudinal data setting we assume that the random effects and within subject errors are normally distributed. However, the normality assumption may not always give robust results,(More)
Bioequivalence assessment is an issue of great interest. Development of statistical methods for assessing bioequivalence is an important area of research for statisticians. Bioequivalence is usually determined based on the normal distribution. We relax this assumption and develop a semi-parametric mixed model for bioequivalence data. The proposed method is(More)